Biofrontera Inc.
BFRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001858685
No open-market purchases or sales by Biofrontera Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Other share classesBFRIW
Q1 2025 vs. Q4 2024
How the institutions holding Biofrontera Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 14 | 12 | −2 |
| Shares | 1.81M | 1.48M | −329.3K (−18.2%) |
| Value | $1.97M | $1.18M | −$787.8K (−39.9%) |
New holders (3)
Institutions that held Biofrontera Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 28,224 | $22.6K | 0.00% |
| JPMorgan Chase & Co | 197 | $158 | 0.00% |
| Morgan Stanley | 160 | $128 | 0.00% |
Sold out (5)
Institutions that held Biofrontera Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Goldman Sachs Group Inc | 45,558 | $49.7K |
| Scotia Capital Inc. | 25,000 | $27.3K |
| Millennium Management LLC | 10,095 | $11.0K |
| Tower Research Capital LLC (TRC) | 4,539 | $4.95K |
| Advisor Group Holdings, Inc. | 576 | $627 |